Clinical efficacy of microencapsulated timothy grass pollen extract in grass-allergic individuals
- 31 January 2004
- journal article
- clinical trial
- Published by Elsevier BV in Annals of Allergy, Asthma & Immunology
- Vol. 92 (1), 25-31
- https://doi.org/10.1016/s1081-1206(10)61706-1
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Oral and sublingual immunotherapy in paediatric patientsCurrent Opinion in Allergy and Clinical Immunology, 2003
- Clinical and immunologic effects of a rush sublingual immunotherapy to Parietaria species: A double-blind, placebo-controlled trialJournal of Allergy and Clinical Immunology, 1999
- Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from TH2 to TH1 in T‐cell clones specific for Phi p 1, a major grass pollen allergenClinical and Experimental Allergy, 1997
- Oral immunotherapy with short ragweed extract in a novel encapsulated preparation: A double-blind studyJournal of Allergy and Clinical Immunology, 1997
- House dust mite immunotherapy results in a decrease in Der p 2‐specific IFN‐γ and IL‐4 expression by circulating T lymphocytesClinical and Experimental Allergy, 1997
- Immunologic Effects of Encapsulated Short Ragweed Extract: a Potent New Agent for Oral ImmunotherapyAnnals of Allergy, Asthma & Immunology, 1996
- Regulatory T Cell Clones Induced by Oral Tolerance: Suppression of Autoimmune EncephalomyelitisScience, 1994
- Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals.The Journal of Experimental Medicine, 1993
- Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses.JCI Insight, 1993
- Double-Blind Pilot Trial of Oral Tolerization with Myelin Antigens in Multiple SclerosisScience, 1993